AC Immune (ACIU) Shareholder's Equity (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.06% |
| Sep 30, 2025 | -13.53% |
| Jun 30, 2025 | -14.38% |
| Mar 31, 2025 | -17.73% |
| Dec 31, 2024 | -14.70% |
| Sep 30, 2024 | 10.08% |
| Jun 30, 2024 | -17.66% |
| Mar 31, 2024 | -8.47% |
| Dec 31, 2023 | 27.29% |
| Sep 30, 2023 | -8.19% |
| Jun 30, 2023 | -6.28% |
| Mar 31, 2023 | -5.74% |
| Dec 31, 2022 | -10.86% |
| Sep 30, 2022 | -6.55% |
| Jun 30, 2022 | -9.18% |
| Mar 31, 2022 | -7.84% |
| Dec 31, 2021 | -99.87% |
| Sep 30, 2021 | -5.96% |
| Jun 30, 2021 | -9.52% |
| Mar 31, 2021 | 96,150.15% |
| Dec 31, 2020 | -5.93% |
| Sep 30, 2020 | -2.67% |
| Jun 30, 2020 | -5.19% |
| Mar 31, 2020 | -0.25% |
| Dec 31, 2019 | -7.24% |
| Sep 30, 2019 | 108,779.06% |
| Jun 30, 2019 | -99.89% |
| Mar 31, 2019 | 36.06% |
| Dec 31, 2017 | -19.98% |
| Sep 30, 2017 | 2.39% |
| Jun 30, 2017 | 9.07% |
| Mar 31, 2017 | -6.93% |
| Dec 31, 2016 | -2.46% |
| Sep 30, 2016 | -0.54% |
| Jun 30, 2016 | 31.96% |
| Mar 31, 2016 | 54.92% |
| Dec 31, 2015 | -16.77% |